HOME >> MEDICINE >> NEWS
Coronary heart disease deaths in Ireland have halved in 15 years

Deaths from coronary artery heart disease in Ireland have halved since the mid 1980s, finds research in the Journal of Epidemiology and Community Health.

Almost half of the drop is attributable to lifestyle changes, especially smoking and diet, it suggests.

The research team used a combination of published data on the use and effectiveness of specific treatments for heart disease and associated risk factors, such as smoking, cholesterol, high blood pressure, obesity, diabetes, and a sedentary lifestyle.

Between 1985 and 2000, deaths from coronary artery disease in Ireland fell by 47% in those aged 25 to 84, resulting in almost 3800 fewer deaths in 2000 than in 1985.

Almost 44% of the drop-off was attributable to better, and more timely, treatment, including tackling heart failure and secondary prevention.

But just under half of the figure (48%) was attributable to sharp falls in smoking, which accounted for over 25%, and in cholesterol, which accounted for 30%. Falls in high blood pressure accounted for 6%.

Smoking rates have fallen more slowly in Ireland than they have in the UK and other developed countries, but have been given a boost by a ban on workplace smoking, which came into force in 2004.

Rises in rates of obesity, diabetes, and sedentary lifestyles offset these favourable trends by around 13% or 500 deaths. And the authors suggest that if these trends continue, they threaten to overturn the substantial health gains made.


'"/>

Contact: Teresa Hagan
thagan@bma.org.uk
207-383-6174
BMJ Specialty Journals
14-Mar-2006


Page: 1

Related medicine news :

1. Coronary surgery -- keeping the way clear
2. CYPHER Sirolimus-eluting Coronary Stent benefits from clinical success, worldwide growth in 2005
3. Sirolimus-eluting Coronary Stent outperforms paclitaxel eluting stent in seven study meta-analysis
4. Sirolimus-eluting Coronary Stent is cost effective vs. bypass surgery
5. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
6. Drug for cluster headaches may cause heart problems
7. Reductive stress linked to heart disease
8. Novel candidate biomarker for heart failure also strongly predicts risk of death
9. Many heart attack patients still not getting emergency clot-busting treatment
10. New heart disease risk score will help minimize health inequalities
11. Metabolic syndrome points to heart health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
(Date:9/19/2017)... ... 2017 , ... MelaKids, a Laredo-based company, has introduced a new concept for ... Nature gives us a full supply of melanin – in the back of the ... glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown pigment in ...
(Date:9/19/2017)... ... 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) , ... in healthcare information exchange and a trusted advisor to the U.S. Department of Health ... entitled Barriers to Adoption of the ERA and EFT Transactions . , ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the ... industry itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. ... natural alkaline water technologies, water filtration systems, and consumer education. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone ... the first in the U.S. to incorporate magnesium, a critical property for bone ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)...  Medical professionals are expected to continuously ... their patients. Medical simulations offer clinicians the ... Simulation provides a safe method for teaching ... refine techniques and build confidence, without putting ... such as augmented reality, will now provide ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology:
Cached News: